Breaking News Instant updates and real-time market news.

USB

U.S. Bancorp

$49.03

-0.25 (-0.51%)

, WFC

Wells Fargo

$52.22

0.1 (0.19%)

06:21
11/23/16
11/23
06:21
11/23/16
06:21

OCC considers tougher bank sanctions after Wells Fargo scandal, Reuters says

The Office of the Comptroller of the Currency, the chief regulator for national banks, is considering whether to stiffen sanctions against lenders that abuse their clients or violate banking laws, Reuters reports, citing a draft plan that was drawn up following a scandal at Wells Fargo. Publicly traded companies in the space include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link

USB

U.S. Bancorp

$49.03

-0.25 (-0.51%)

WFC

Wells Fargo

$52.22

0.1 (0.19%)

MS

Morgan Stanley

$40.54

-0.02 (-0.05%)

BAC

Bank of America

$20.30

-0.03 (-0.15%)

GS

Goldman Sachs

$211.11

0.03 (0.01%)

C

Citi

$56.10

0.56 (1.01%)

JPM

JPMorgan

$78.53

0.48 (0.61%)

  • 01

    Dec

  • 06

    Dec

  • 06

    Dec

  • 13

    Jan

  • 26

    Jan

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

USB U.S. Bancorp
$49.03

-0.25 (-0.51%)

11/16/16
PIPR
11/16/16
DOWNGRADE
Target $48
PIPR
Neutral
U.S. Bancorp downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Kevin Barker downgraded U.S. Bancorp to Neutral saying the stock is fully valued following the recent rally. The analyst has a $48 price target for the shares.
11/14/16
MSCO
11/14/16
DOWNGRADE
Target $49
MSCO
Underweight
U.S. Bancorp downgraded to Underweight on relative valuation at Morgan Stanley
As previously reported, Morgan Stanley upgraded U.S. Bancorp to Underweight from Equal Weight and raised its price target to $49 from $46. Analysts led by Betsy Graseck said the Republican sweep is positive for all financial stocks due to increased growth, higher rates, lower taxes, and less regulation but downgraded U.S. Bancorp citing relative valuation and sees risks of slower loan growth, deteriorating credit, lower fee growth, and declining NIM.
11/14/16
MSCO
11/14/16
DOWNGRADE
MSCO
Underweight
U.S. Bancorp downgraded to Underweight from Equal Weight at Morgan Stanley
10/06/16
WEDB
10/06/16
INITIATION
Target $46
WEDB
Neutral
U.S. Bancorp initiated with a Neutral at Wedbush
Wedbush analyst Peter Winter initiated U.S. Bancorp with a Neutral and a $46 price target.
WFC Wells Fargo
$52.22

0.1 (0.19%)

11/18/16
11/18/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Underperform from Market Perform at BMO Capital with analyst James Fotheringham saying that the shares don't reflect the impact of its "recent cross-selling issues." 2. Gap (GPS) downgraded to Sell from Neutral at Citi with analyst Paul Lejuez citing expectations that the company's brands will continue to struggle. 3. Citi (C) downgraded to Neutral from Outperform at Macquarie with analyst David Konrad saying investors should shift exposure to names that have more leverage to capital markets and increased economic activity and away from global banks. 4. Torchmark (TMK) downgraded to Underperform from Neutral at BofA/Merrill with analyst Seth Weiss citing relative valuation. 5. First Solar (FSLR) downgraded to Sell from Neutral at UBS with analyst Julien Dumoulin-Smith saying the recently issued 2017 guidance "is not the trough in expectations." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/18/16
BMOC
11/18/16
DOWNGRADE
BMOC
Underperform
Wells Fargo downgraded on valuiation at BMO Capital
As noted earlier, BMO Capital downgraded Wells Fargo to Underperform from Market Perform. Analyst James Fotheringham downgraded the stock based on valuation, saying that the shares don't reflect the impact of its "recent cross-selling issues." Target $47.
11/18/16
BMOC
11/18/16
DOWNGRADE
BMOC
Underperform
Wells Fargo downgraded to Underperform from Market Perform at BMO Capital
11/17/16
RAFF
11/17/16
UPGRADE
RAFF
Hold
Wells Fargo upgraded to Hold from Sell at Rafferty Capital
MS Morgan Stanley
$40.54

-0.02 (-0.05%)

10/06/16
SDLR
10/06/16
DOWNGRADE
Target $33
SDLR
Hold
Morgan Stanley downgraded to Hold from Buy at Sandler O'Neill
Sandler O'Neill analyst Jeffery Harte downgraded Morgan Stanley to Hold citing relative share outperformance and maintained his $33 price target on shares.
11/18/16
MACQ
11/18/16
DOWNGRADE
MACQ
Neutral
Citi downgraded to Neutral from Outperform at Macquarie
Macquarie analyst David Konrad downgraded Citi (C) to Neutral saying investors should shift exposure to names that have more leverage to capital markets and increased economic activity and away from global banks. He believes the valuations of global banks may "remain suppressed" amid decreased trade and currency volatility. The analyst has a $57 price target for the shares. Citi closed yesterday up 82c to $55.45. Konrad this morning also upgraded Goldman Sachs (GS) to Outperform and reiterated an Outperform rating on Morgan Stanley (MS).
10/20/16
GUGG
10/20/16
UPGRADE
GUGG
Buy
Morgan Stanley upgraded to Buy from Neutral at Guggenheim
10/20/16
GUGG
10/20/16
UPGRADE
Target $39
GUGG
Buy
Morgan Stanley upgraded to Buy on improved mix at Guggenheim
As previously reported, Guggenheim upgraded Morgan Stanley to Buy from Neutral with a $39 price target. Analyst Eric Wasserstrom raised estimates to reflect improved revenue mix and operating leverage following the better than expected Q3 report. He believes improved mix of its business and asset composition will benefit Morgan Stanley's future CCAR stress tests and result in greater excess regulatory capital and views risk/reward as positive.
BAC Bank of America
$20.30

-0.03 (-0.15%)

11/16/16
BARD
11/16/16
DOWNGRADE
BARD
Neutral
Bank of America downgraded to Neutral from Outperform at Baird
11/15/16
11/15/16
DOWNGRADE

Neutral
Bank of America downgraded to Neutral on valuation at Guggenheim
As previously reported, Guggenheim downgraded Bank of America to Neutral from Buy and raised its price target to $22 from $19. Analyst Eric Wasserstrom said valuation embeds his above consensus earnings estimate for 2017-18 and any upside will be increasingly driven by macro-factors rather than company specific drivers.
11/16/16
11/16/16
DOWNGRADE
Target $18

Neutral
Bank of America downgraded to Neutral from Outperform at Baird
As previously reported, Baird analyst David George downgraded Bank of America to Neutral from Buy as he believes the post-election rally has largely discounted the potential benefits of rising interest rates, lower taxes, and more aggressive capital return. George raised his price target to $18 from $17 on Bank of America shares.
11/16/16
11/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Sysco (SYY) downgraded to Neutral from Outperform at Credit Suisse with analyst Edward Kelly saying Sysco shares are up 50% over the last 18 months and now views risk/reward as balanced. 2. Teva (TEVA) downgraded to Hold from Buy at Jefferies, to Equal Weight from Overweight at Morgan Stanley, and to Neutral from Buy at BTIG. 3. Bank of America (BAC) Capital One (COF) downgraded to Neutral from Outperform at Baird while the firm downgraded Fifth Third (FITB) to Underperform from Neutral. 4. Zions Bancorp (ZION) downgraded to Equal Weight from Overweight at Morgan Stanley and to Market Perform from Outperform at Bernstein. 5. Yingli Green Energy (YGE) downgraded to Sell from Buy at Axiom while the firm downgraded SolarCity (SCTY) and JA Solar (JASO) to Sell from Hold. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GS Goldman Sachs
$211.11

0.03 (0.01%)

11/18/16
MACQ
11/18/16
UPGRADE
Target $245
MACQ
Outperform
Goldman Sachs upgraded to Outperform from Neutral at Macquarie
Macquarie analyst David Konrad upgraded Goldman Sachs to Outperform saying investors should shift exposure to names that have more leverage to capital markets and increased economic activity and away from global banks. The analyst has a $245 price target for the shares.
11/18/16
11/18/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. HP Enterprise (HPE) upgraded to Outperform from Market Perform at Raymond James with analyst Simon Leopold saying he believes the spinoff of its Enterprise Service and Software businesses will unlock value and said checks have been positively biased in North American enterprises and Federal verticals. 2. Exelon (EXC) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Stephen Byrd saying Exelon offers attractive growth at a compelling valuation with meaningful ROE improvement at acquired utilities. 3. Goldman Sachs (GS) upgraded to Outperform from Neutral at Macquarie with saying investors should shift exposure to names that have more leverage to capital markets and increased economic activity and away from global banks. 4. Hain Celestial (HAIN) upgraded to Neutral from Underperform at BofA/Merrill and to Neutral from Underweight at Atlantic Equities. 5. FleetCor (FLT) upgraded to Outperform from Market Perform at Wells Fargo with analyst Timothy Willi saying the 13% selloff since the company's third quarter results on November 1 is overdone and presents a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/10/16
RAFF
11/10/16
NO CHANGE
Target $227
RAFF
Buy
Goldman Sachs price target raised to $227 from $191 at Rafferty Capital
C Citi
$56.10

0.56 (1.01%)

11/18/16
11/18/16
INITIATION
Target $65

Underweight
American Express initiated with an Underweight at Stephens
As previously reported, Stephens analyst started American Express (AXP) with an Underweight rating and $65 price target, citing rising rates, shrinking markets as American Express ramps up rewards to maintain share, and the risk to 2017 EPS guidance. The analyst expects competition from bank peers, such as JPMorgan (JPM) and Citi (C), to continue to pressure American Express' earnings.
11/14/16
11/14/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lockheed Martin (LMT) upgraded to Buy from Hold at Stifel with analyst Joseph DeNardi saying he is pleased with the company's comments regarding its 2018 free cash flow outlook, and he thinks that it could benefit from increased defense spending in the wake of the election results. 2. Philip Morris (PM) upgraded to Buy from Outperform at CLSA with analyst Michael Levy citing the recent pullback for his rating change and said he sees the company adding to its buyback. 3. Citi (C) upgraded to Overweight from Equal Weight at Morgan Stanley with analysts led by Betsy Graseck saying the Republican sweep is positive for all financial stocks due to increased growth, higher rates, lower taxes, and less regulation. 4. U.S. Steel (X) and AK Steel (AKS) upgraded to Overweight from Equal Weight at Morgan Stanley. 5. L Brands (LB), Kohl's (KSS), and Chico's(CHS) were upgraded to Buy from Neutral at Citi, while Chico's was also upgraded to Outperform from Peer Perform at Wolfe Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
JPM JPMorgan
$78.53

0.48 (0.61%)

11/11/16
RBCM
11/11/16
NO CHANGE
RBCM
Banks to benefit from higher interest rates, says RBC Capital
RBC Capital believes that the Fed is committed to raising interest rates, and it expects FOMC members' forecast to show they expect two rate increases to occur in 2017. The firm expects higher rates to boost banks' net interest margin, raising their profits. It identifies Bank of America (BAC), JPMorgan (JPM), Citizens Financial (CFG),M&T Bank (MTB), and Regions Financial (RF) as being among the banks most likely to benefit from short-term rate increases.
11/09/16
BARD
11/09/16
DOWNGRADE
Target $72
BARD
Neutral
JPMorgan downgraded to Neutral at Baird
As reported previously, Baird analyst David George downgraded JPMorgan to Neutral from Outperform. The analyst noted its outperformance and the higher re-rating of its valuation multiple. George believes investors should reduce their risk heading into a potential interest rate hike. He maintained his $72 price target on JPMorgan shares.
11/09/16
11/09/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan (JPM) downgraded to Neutral from Outperform at Baird with analyst David George noting the stock's outperformance and the higher re-rating of its valuation multiple. 2. GoPro (GPRO) downgraded to Neutral from Outperform at Wedbush, to Market Perform from Outperform at Raymond James, and to Sell from Neutral at Dougherty. 3. Universal Health (UHS) downgraded to Neutral from Buy at BofA/Merrill, to Neutral from Buy at Mizuho, and to Market Perform from Outperform at Avondale. 4. Globus Medical (GMED) downgraded to Market Perform from Outperform at JMP Securities, to Perform from Outperform at Oppenheimer, and to Market Perform from Outperform at William Blair. 5. Delphi (DLPH) and Magna (MGA) were downgraded to Underperform from Buy at BofA/Merrill while the firm downgraded Lear (LEA), American Axle (AXL), Adient (ADNT), and BorgWarner (BWA) to Underperform from Neutral. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

AVEO

Aveo Oncology

$2.77

-0.05 (-1.77%)

14:32
01/19/18
01/19
14:32
01/19/18
14:32
Hot Stocks
AVEO says tivozanib study results show 'favorable' response rate, safety profile »

AVEO Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

BLK

BlackRock

$587.22

8 (1.38%)

, SNBR

Sleep Number

$37.00

-1.11 (-2.91%)

14:25
01/19/18
01/19
14:25
01/19/18
14:25
Hot Stocks
BlackRock reports 12.6% passive stake in Sleep Number »

In a regulatory filing,…

BLK

BlackRock

$587.22

8 (1.38%)

SNBR

Sleep Number

$37.00

-1.11 (-2.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

LEG

Leggett & Platt

$48.15

-0.21 (-0.43%)

14:20
01/19/18
01/19
14:20
01/19/18
14:20
Options
Put buying in Leggett and Platt »

Put buying in Leggett and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:20
01/19/18
01/19
14:20
01/19/18
14:20
General news
Fedspeak will be truncated next week »

Fedspeak will be…

$NSD

NASDAQ Market Internals

14:17
01/19/18
01/19
14:17
01/19/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
01/19/18
01/19
14:16
01/19/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$179.80

2.2 (1.24%)

, AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

14:08
01/19/18
01/19
14:08
01/19/18
14:08
Periodicals
Facebook not bidding for Thursday Night Football rights, Bloomberg reports »

Facebook (FB) has decided…

FB

Facebook

$179.80

2.2 (1.24%)

AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

HPQ

HP Inc.

$23.62

0.33 (1.42%)

14:06
01/19/18
01/19
14:06
01/19/18
14:06
Conference/Events
HP Inc. to hold a webcast »

Global Head of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 22

    Jan

RENN

Renren

$10.96

-0.16 (-1.44%)

14:05
01/19/18
01/19
14:05
01/19/18
14:05
Options
Renren call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$3.66

0.03 (0.83%)

14:04
01/19/18
01/19
14:04
01/19/18
14:04
Hot Stocks
Tonix: Horsepox virus showed protection vs. lethal vaccinia infection in study »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLK

BlackRock

$587.11

7.89 (1.36%)

, CIR

Circor

$53.40

1.12 (2.14%)

14:04
01/19/18
01/19
14:04
01/19/18
14:04
Hot Stocks
BlackRock reports 12.6% passive stake in Circor »

In a regulatory filing,…

BLK

BlackRock

$587.11

7.89 (1.36%)

CIR

Circor

$53.40

1.12 (2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 22

    Feb

VIA

Viacom

$39.70

1.85 (4.89%)

, FOXA

21st Century Fox

$36.18

-0.93 (-2.51%)

14:04
01/19/18
01/19
14:04
01/19/18
14:04
Hot Stocks
Box Office Battle: 'Jumanji,' 'The Post' expected to hold off '12 Strong' »

Still expected to remain…

VIA

Viacom

$39.70

1.85 (4.89%)

FOXA

21st Century Fox

$36.18

-0.93 (-2.51%)

LGF.B

Lionsgate

$33.25

0.41 (1.25%)

VIAB

Viacom

$33.95

1.99 (6.23%)

CMCSA

Comcast

$41.85

0.17 (0.41%)

CMCSK

Comcast

LGF.A

Lionsgate

$35.22

0.72 (2.09%)

TWX

Time Warner

$92.90

-0.07 (-0.08%)

DIS

Disney

$110.18

-0.24 (-0.22%)

SNE

Sony

$49.80

0.63 (1.28%)

FOX

21st Century Fox

$35.73

-0.76 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

BLK

BlackRock

$586.98

7.76 (1.34%)

, BXS

BancorpSouth

$34.90

0.35 (1.01%)

14:02
01/19/18
01/19
14:02
01/19/18
14:02
Hot Stocks
BlackRock reports 10.2% passive stake in BancorpSouth »

In a regulatory filing,…

BLK

BlackRock

$586.98

7.76 (1.34%)

BXS

BancorpSouth

$34.90

0.35 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 25

    Jan

14:00
01/19/18
01/19
14:00
01/19/18
14:00
General news
Action Economics Survey results: »

Action Economics Survey…

BASFY

BASF

$29.54

0.825 (2.87%)

, BAYRY

Bayer

$31.82

0.015 (0.05%)

13:57
01/19/18
01/19
13:57
01/19/18
13:57
Periodicals
Breaking Periodicals news story on BASF, Bayer »

Capitol Forum says BASF,…

BASFY

BASF

$29.54

0.825 (2.87%)

BAYRY

Bayer

$31.82

0.015 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 25

    Mar

13:55
01/19/18
01/19
13:55
01/19/18
13:55
General news
SF Fed moderate Williams said economic tailwinds »

SF Fed moderate Williams…

OCPNY

Olympus Corp

$38.27

-0.12 (-0.31%)

13:54
01/19/18
01/19
13:54
01/19/18
13:54
Hot Stocks
Judge grants new trial for Bigler Family vs. Olympus wrongful-death case »

A King County court has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$77.99

0.6 (0.78%)

13:52
01/19/18
01/19
13:52
01/19/18
13:52
Periodicals
Citi plans to have post-Brexit trading hub running by year end, Bloomberg says »

Citigroup intends to have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 24

    Jan

CANF

Can-Fite BioPharma

$1.76

0.01 (0.57%)

13:50
01/19/18
01/19
13:50
01/19/18
13:50
Conference/Events
Can-Fite BioPharma participates in lunch meeting with Philadelphia Securities »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

13:50
01/19/18
01/19
13:50
01/19/18
13:50
Options
VIX slips on a relatively quiet monthly expiration »

VIX slips on a relatively…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:50
01/19/18
01/19
13:50
01/19/18
13:50
General news
Oil Action: Baker-Hughes »

Oil Action: Baker-Hughes…

KMI

Kinder Morgan

$18.97

-0.045 (-0.24%)

13:45
01/19/18
01/19
13:45
01/19/18
13:45
Options
Post earnings premium seller collects $13M in KinderMorgan »

Post earnings premium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$91.92

1.61 (1.78%)

13:45
01/19/18
01/19
13:45
01/19/18
13:45
Options
Incyte call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

PRQR

ProQR Therapeutics

13:31
01/19/18
01/19
13:31
01/19/18
13:31
Conference/Events
ProQR Therapeutics to h old an investor event »

Investor Event will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

CMC

Commercial Metals

$24.83

-0.26 (-1.04%)

13:30
01/19/18
01/19
13:30
01/19/18
13:30
Options
Second day of call buying in Commercial Metals »

Second day of call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.